Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Stock indices provide benchmarks and a lens into market trends. This overview explains their purpose and how investors leverage them.
16,698 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
A single insider trade can spark headlines, but it isn’t a crystal ball. This guide explains how to read a director s...
When tech giants join forces, investors take notice. This article breaks down the huge news nebius stock and why Meta...
Regulatory headlines have a way of rattling investors, especially in high-growth tech sectors. This article dives int...
Palantir faces a pivotal moment as 2025 results reinforce growth in AI-related revenue, yet lofty valuations keep inv...
Mega-IPOs grab headlines, but what sticks after the first week? This article breaks down the five biggest IPOs in his...
Institutional moves can quietly reshape a stock's risk and reward. This article looks at Levin's trim of O-I Glass an...
NVIDIA’s latest announcements are stirring chatter about AI-driven growth and new catalysts. Here’s what investors sh...
Friday’s slide left many investors asking what’s next. This guide highlights three stocks that bounce back, why they ...
Imagine a blockbuster SpaceX IPO that raises $75 billion and pays banks a record underwriting fee. This article break...
Nvidia sits at the center of a rapid AI infrastructure buildout. Here’s how the stock could move by 2029, based on gr...
SpaceX's IPO excitement gave way to a pullback, leaving investors wondering about future gains. This guide breaks dow...